- Home
- TSHA vs MOFG Comparison
TSHA vs MOFG Comparison
Compare TSHA & MOFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- MOFG
- Stock Information
- Founded
- TSHA 2019
- MOFG 1934
- Country
- TSHA United States
- MOFG United States
- Employees
- TSHA N/A
- MOFG N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- MOFG Major Banks
- Sector
- TSHA Health Care
- MOFG Finance
- Exchange
- TSHA Nasdaq
- MOFG Nasdaq
- Market Cap
- TSHA 397.8M
- MOFG 422.7M
- IPO Year
- TSHA 2020
- MOFG N/A
- Fundamental
- Price
- TSHA $2.13
- MOFG $28.81
- Analyst Decision
- TSHA Strong Buy
- MOFG Buy
- Analyst Count
- TSHA 8
- MOFG 2
- Target Price
- TSHA $6.63
- MOFG $35.50
- AVG Volume (30 Days)
- TSHA 3.0M
- MOFG 102.4K
- Earning Date
- TSHA 05-16-2025
- MOFG 04-24-2025
- Dividend Yield
- TSHA N/A
- MOFG 3.37%
- EPS Growth
- TSHA N/A
- MOFG N/A
- EPS
- TSHA N/A
- MOFG N/A
- Revenue
- TSHA $8,333,000.00
- MOFG $76,604,000.00
- Revenue This Year
- TSHA N/A
- MOFG $237.51
- Revenue Next Year
- TSHA N/A
- MOFG $5.96
- P/E Ratio
- TSHA N/A
- MOFG N/A
- Revenue Growth
- TSHA N/A
- MOFG N/A
- 52 Week Low
- TSHA $1.05
- MOFG $20.04
- 52 Week High
- TSHA $4.32
- MOFG $34.56
- Technical
- Relative Strength Index (RSI)
- TSHA 58.69
- MOFG 56.43
- Support Level
- TSHA $1.85
- MOFG $28.17
- Resistance Level
- TSHA $2.28
- MOFG $29.63
- Average True Range (ATR)
- TSHA 0.26
- MOFG 1.16
- MACD
- TSHA 0.03
- MOFG 0.19
- Stochastic Oscillator
- TSHA 52.96
- MOFG 78.87
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About MOFG MidWestOne Financial Gp
MidWestOne Financial Group Inc is a bank holding company engaged in delivering relationship-based business and personal banking products and services. The Bank provides commercial loans, real estate loans, agricultural loans, credit card loans, and consumer loans. It also provides deposit products including demand and interest checking accounts, savings accounts, money market accounts, and time deposits. The Bank also provides products and services including treasury management, Zelle, online and mobile banking, debit cards, ATMs, and safe deposit boxes. The Bank offers its products and services through its network of full-service banking offices. the Bank's investments services department offers financial planning, investment advisory, and retail securities brokerage services.